CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
Significant progress has been achieved in the realm of therapeutic 4 Channel LOC interventions for multiple myeloma (MM), leading to transformative shifts in its clinical management.While conventional modalities such as surgery, radiotherapy, and chemotherapy have improved the clinical outcomes, the overarching challenge of effecting a comprehensiv